Date	Period	Revenue/Estimate	Earnings Call
Nov 11, 2021	2021/Q3	2.407B / --	--
May 13, 2021	2021/Q1	1.420B / --	--
Nov 10, 2020	2020/Q3	972.000M / --	--
May 12, 2020	2020/Q1	551.000M / --	--
Nov 8, 2019	2019/Q3	4.000M / --	--

DatePeriodRevenue/EstimateEarnings Call

Nov 11, 20212021/Q32.407B / ----

May 13, 20212021/Q11.420B / ----

Nov 10, 20202020/Q3972.000M / ----

May 12, 20202020/Q1551.000M / ----

Nov 8, 20192019/Q34.000M / ----

Unlock Free Earnings Estimates

Open Account

SymBio Pharmaceuticals: Summary of Financial Results for the Fiscal Year Ending 2024/12 [Japanese GAAP] (Consolidated)

Feb 6 01:35 ET

SymBio Pharmaceuticals: Summary of Financial Results for the 3rd Quarter Ending 2024/12 [Japanese GAAP] (Consolidated)

Oct 31, 2024 02:30 ET

SymBio Pharmaceuticals: Confirmatory letter.

Aug 2, 2024 02:06 ET

SymBio Pharmaceuticals: Semiannual Report - 20th Period (01/01/2024 - 12/31/2024)

Aug 2, 2024 02:05 ET

Symbol Price % Chg

See the daily top gainer.